search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Delirium treatment at the surgical ward (DELTa S) Treatment of delirium: rivastigmine or haloperidol as primary treatment for delirium in elderly patients with a fractured hip. A randomized placebo-controlled study.


- candidate number1855
- NTR NumberNTR537
- ISRCTNIncomplete data for ISRCTN
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR25-nov-2005
- Secondary IDsN/A 
- Public TitleDelirium treatment at the surgical ward (DELTa S) Treatment of delirium: rivastigmine or haloperidol as primary treatment for delirium in elderly patients with a fractured hip. A randomized placebo-controlled study.
- Scientific TitleDelirium treatment at the surgical ward (DELTa S) Treatment of delirium: rivastigmine or haloperidol as primary treatment for delirium in elderly patients with a fractured hip. A randomized placebo-controlled study.
- ACRONYMDELTa S
- hypothesisRivastigmine is as effective in the treatment of delirium as Haloperidol.
- Healt Condition(s) or Problem(s) studiedDelirium
- Inclusion criteriaPatients with a fractured hip, admitted on a surgical ward.
- Exclusion criteriaAlready use of Haloperidol/Rivastigmine/Donepezil/Galantamine.
- mec approval receivedyes
- multicenter trialno
- randomisedyes
- masking/blindingDouble
- controlPlacebo
- group[default]
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-jan-2006
- planned closingdate1-jan-2009
- Target number of participants100
- InterventionsHaloperidol or rivastigmine for the treatment of delirium.
- Primary outcomeLength of delirium.
- Secondary outcome1. Length of stay hospital;
2. Severity of delirium;
3. Functional outcome 3,6,13 weeks after delirium;
4. Need of escape medication;
5. Cognition;
6. Adverse events.
- TimepointsN/A
- Trial web siteN/A
- statusstopped
- CONTACT FOR PUBLIC QUERIESDrs. R.J.A. Wensen, van
- CONTACT for SCIENTIFIC QUERIESDr. P.L.J. Dautzenberg
- Sponsor/Initiator
- Funding
(Source(s) of Monetary or Material Support)
Novartis Pharma B.V.
- PublicationsN/A
- Brief summaryN/A
- Main changes (audit trail)
- RECORD25-nov-2005 - 16-sep-2010


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl